Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs

References

• TongJ, MeyerJH, FurukawaY, et al. Distribution of monoamine oxidase proteins in human brain: Implications for brain imaging studies. J Cereb Blood Flow Metab. 2013;33(6):863–871. doi:10.1038/jcbfm.2013.1923403377
   PubMed Web of Science ®Google Scholar
• RamsayRR, AlbrehtA. Kinetics, mechanism, and inhibition of monoamine oxidase. J Neural Transm. 2018;125(11):1659–1683. doi:10.1007/s00702-018-1861-929516165
   PubMed Web of Science ®Google Scholar
• KimJ, KangS, HongS, YumS, KimYM, JungY. Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis. Eur J Med Chem. 2012;48:36–44. doi:10.1016/j.ejmech.2011.11.03022154834
   PubMed Web of Science ®Google Scholar
• HiltonS, JaberB, RuchR. Moclobemide safety: Monitoring a newly developed product in the 1990s. J Clin Psychopharmacol. 1995;15(4):76S–83S. doi:10.1097/00004714-199508001-000137593735
   PubMed Web of Science ®Google Scholar
• UlrichS, RickenR, AdliM. Tranylcypromine in mind (Part I): Review of pharmacology. Eur Neuropsychopharmacol. 2017;27(8):697–713. doi:10.1016/j.euroneuro.2017.05.00728655495
   PubMed Web of Science ®Google Scholar
• BorštnarR, RepičM, KržanM, MavriJ, VianelloR. Irreversible inhibition of monoamine oxidase B by the antiparkinsonian medicines rasagiline and selegiline: A computational study. Eur J Org Chem. 2011;2011(32):6419–6433. doi:10.1002/ejoc.v2011.32
   Web of Science ®Google Scholar
• BetteS, ShpinerDS, SingerC, MooreH. Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: A review of the current clinical evidence. Ther Clin Risk Manag. 2018;14:1737–1745. doi:10.2147/TCRM.S13954530271159
   PubMed Web of Science ®Google Scholar
• KumarB, SheetalMAK, KumarV. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors. Bioorg Chem. 2018;77:252–262. doi:10.1016/j.bioorg.2018.01.02029421700
   PubMed Web of Science ®Google Scholar
• ReisJ, ManzellaN, CagideF, et al. Tight-binding inhibition of human monoamine oxidase B by chromone analogs: A kinetic, crystallographic, and biological analysis. J Med Chem. 2018;61(9):4203–4212. doi:10.1021/acs.jmedchem.8b0035729648817
   PubMed Web of Science ®Google Scholar
• RamsayRR, Popovic-NikolicMR, NikolicK, UliassiE, BolognesiML. A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med. 2018;7(1):3–17. doi:10.1186/s40169-017-0181-229340951
   PubMed Web of Science ®Google Scholar
• MathewB, ParambiDGT, MathewGE, et al. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer’s and Parkinson’s diseases. Arch Pharm. 2019;352(11):1–13. doi:10.1002/ardp.201900177
   Web of Science ®Google Scholar
• TakaoK, YahagiH, UesawaY, SugitaY. 3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg Chem. 2018;77:436–442. doi:10.1016/j.bioorg.2018.01.03629448189
   PubMed Web of Science ®Google Scholar
• Van DykAS, PetzerJP, PetzerA, LegoabeLJ. 3-Coumaranone derivatives as inhibitors of monoamine oxidase. Drug Des Devel Ther. 2015;9:5479–5489. doi:10.2147/DDDT.S89961
   PubMed Web of Science ®Google Scholar
• ReisJ, CagideF, ChavarriaD, et al. Discovery of new chemical entities for old targets: Insights on the lead optimization of chromone-based monoamine oxidase B (MAO-B) inhibitors. J Med Chem. 2016;59(12):5879–5893. doi:10.1021/acs.jmedchem.6b0052727244485
   PubMed Web of Science ®Google Scholar
• LegoabeLJ, PetzerA, PetzerJP. 2-Acetylphenol analogs as potent reversible monoamine oxidase inhibitors. Drug Des Devel Ther. 2015;9:3635–3644. doi:10.2147/DDDT.S86225
   PubMed Web of Science ®Google Scholar
• AhmadS, ZaibS, JalilS, et al. Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivatives. Bioorg Chem. 2018;80:498–510. doi:10.1016/j.bioorg.2018.04.01229996111
   PubMed Web of Science ®Google Scholar
• AiN, WoodRD, YangE, WelshWJ. Niclosamide is a negative allosteric modulator of Group I metabotropic glutamate receptors: implications for neuropathic pain. Pharm Res. 2016;33(12):3044–3056. doi:10.1007/s11095-016-2027-927631130
   PubMed Web of Science ®Google Scholar
• KumarA, NarasimhanB, KumarD. Synthesis, antimicrobial, and QSAR studies of substituted benzamides. Bioorg Med Chem. 2007;15:4113–4124. doi:10.1016/j.bmc.2007.03.07417428669
   PubMed Web of Science ®Google Scholar
• LiY, WangY, WangJ. Microwave-promoted conversion of heterocyclic amines to corresponding amides under solvent-free conditions. Heterocycl Commun. 2007;13(4):251–256. doi:10.1515/HC.2007.13.4.251
   Web of Science ®Google Scholar
• LiL, HanJ, NguyenB, BurgessK. Syntheses and spectral properties of functionalized, water-soluble BODIPY derivatives. J Org Chem. 2008;73(5):1963–1970. doi:10.1021/jo702463f18271598
   PubMed Web of Science ®Google Scholar
• AffiniA, HagenowS, ZivkovicA, Marco-ContellesJ, StarkH. Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson’s disease. Eur J Med Chem. 2018;148:487–497. doi:10.1016/j.ejmech.2018.02.01529477889
   PubMed Web of Science ®Google Scholar
• MostertS, PetzerA, PetzerJP. Inhibition of monoamine oxidase by benzoxathiolone analogues. Bioorg Med Chem Lett. 2016;26(4):1200–1204. doi:10.1016/j.bmcl.2016.01.03426821818
   PubMed Web of Science ®Google Scholar
• SonS-Y, MaJ, KondouY, YoshimuraM, YamashitaE, TsukiharaT. Human monoamine oxidase A: Structure and control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci USA. 2008;105(15):5739–5744. doi:10.1073/pnas.071062610518391214
   PubMed Web of Science ®Google Scholar
• VerdonkML, BerdiniV, HartshornMJ, et al. Virtual screening using protein-ligand docking: Avoiding artificial enrichment. J Chem Inf Comput Sci. 2004;44(3):793–806. doi:10.1021/ci034289q15154744
   PubMedGoogle Scholar
• FrédérickR, DumontW, OomsF, et al. Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indeno[1,2-c]pyridazin-5-one core. J Med Chem. 2006;49(12):3743–3747. doi:10.1021/jm051091j16759116
   PubMed Web of Science ®Google Scholar
• La ReginaG, SilvestriR, ArticoM, et al. New pyrrole inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. J Med Chem. 2007;50(5):922–931. doi:10.1021/jm060882y17256833
   PubMed Web of Science ®Google Scholar
• European Medicines Agency [homepage on the Internet]. Human medicines highlights 2018. Authorisation of new medicines. Available from: https://www.ema.europa.eu/en/news/human-medicines-highlights-2018. Accessed 9 5, 2019.
   Google Scholar
• TzvetkovNT, StammlerHG, HristovaS, AtanasovAG, AntonovL. (Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. Eur J Med Chem. 2019;162:793–809. doi:10.1016/j.ejmech.2018.11.00930522087
   PubMed Web of Science ®Google Scholar
• TzvetkovNT, StammlerHG, GeorgievaMG, et al. Carboxamides vs. methanimines: crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. Eur J Med Chem. 2019;179:404–422. doi:10.1016/j.ejmech.2019.06.04131265934
   PubMed Web of Science ®Google Scholar
• VishnuMS, PavankumarV, KumarS, RajaAS. Experimental and computational evaluation of piperonylic acid derived hydrazones bearing isatin moieties as dual inhibitors of cholinesterases and monoamine oxidases. Chem Med Chem. 2019;14:1359–1376. doi:10.1002/cmdc.v14.1431177620
   PubMed Web of Science ®Google Scholar
• ZhangC, YangK, YuS, et al. Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer’s disease. Eur J Med Chem. 2019;180:367–382. doi:10.1016/j.ejmech.2019.07.03131325784
   PubMed Web of Science ®Google Scholar
• PisaniL, IacobazziRM, CattoM, et al. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors. Eur J Med Chem. 2019;161:292–309. doi:10.1016/j.ejmech.2018.10.01630366255
   PubMed Web of Science ®Google Scholar
• RamsayRR, MajekovaM, MedinaM, ValotiM. Key targets for multi-target ligands designed to combat neurodegeneration. Front Neurosci. 2016;10. doi:10.3389/fnins.2016.00375
   Web of Science ®Google Scholar
• DesaiKR, ShaikhMS, CoutinhoEC. Molecular modeling studies, synthesis and biological evaluation of derivatives of N-phenylbenzamide as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors. Med Chem Res. 2011;20(3):321–332. doi:10.1007/s00044-010-9323-4
   Web of Science ®Google Scholar
• XuX, LiP, HuangY, TongC, YanYY, XieY. Atmospheric oxidative catalyst-free cross-dehydrogenative coupling of aldehydes with N-hydroxyimides. Tetrahedron Lett. 2017;58(18):1742–1746. doi:10.1016/j.tetlet.2017.03.064
   Web of Science ®Google Scholar
• FerrinsL, GazdikM, RahmaniR, et al. Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei. J Med Chem. 2014;57(15):6393–6402. doi:10.1021/jm500191u24978605
   PubMed Web of Science ®Google Scholar
• OckeyDA, DotsonJL, StrubleME, et al. Structure-activity relationships by mass spectrometry: Identification of novel MMP-3 inhibitors. Bioorg Med Chem. 2004;12(1):37–44. doi:10.1016/j.bmc.2003.10.05314697768
   PubMed Web of Science ®Google Scholar
• WenQ, JinJ, MeiY, LuP, WangY. Copper-mediated cyanation of aryl halides by activation of benzyl cyanide as the cyanide source. Eur J Org Chem. 2013;2013(19):4032–4036. doi:10.1002/ejoc.201300052
   Web of Science ®Google Scholar
• DeshidiR, RizviMA, ShahBA. Highly efficient dehydrogenative cross-coupling of aldehydes with amines and alcohols. RSC Adv. 2015;5(110):90521–90524. doi:10.1039/C5RA17425B
   Web of Science ®Google Scholar
• HongG, WuS, ZhuX, MaoD, WangL. Peroxide-mediated direct synthesis of amides from aroyl surrogates. Tetrahedron. 2016;72(3):436–441. doi:10.1016/j.tet.2015.11.063
   Web of Science ®Google Scholar
• ScarboroughR, JantzenH-M, HuangW, et al. Platelet ADP receptor inhibitors. European Patent EP 2314593A1. 2011.
   Google Scholar
• SrinivasachariR, RamaswamiS, AshaK. Quinone imine route to benzimidazol-2-ylcarbamates. Part 1. Synthesis of open-chain and cyclic 5-acylamino derivatives. J Chem Res Miniprint. 1986;1657–1675.
   Web of Science ®Google Scholar
• SunY, WangG, GuoW. Colorimetric detection of cyanide with N-nitrophenyl benzamide derivatives. Tetrahedron. 2009;65(17):3480–3485. doi:10.1016/j.tet.2009.02.023
   Web of Science ®Google Scholar
• ShengWJ, YeQ, BinYW, et al. CuSO4 -mediated decarboxylative C-N cross-coupling of aromatic carboxylic acids with amides and anilines. Tetrahedron Lett. 2015;56(4):599–601. doi:10.1016/j.tetlet.2014.12.085
   Web of Science ®Google Scholar
• DownerNK, JacksonYA, IndiesW. Synthesis of benzothiazoles via ipso substitution of ortho-methoxythiobenzamides. Org Biomol Chem. 2004;2:3039–3043. doi:10.1039/b410373d15480469
   PubMed Web of Science ®Google Scholar
• CarboneG, BurnleyJ, MosesJE. A catalytic and tert-butoxide ion-mediated amidation of aldehydes with para-nitro azides. Chem Commun. 2013;49(27):2759–2761. doi:10.1039/c3cc40452h
   PubMed Web of Science ®Google Scholar
• BasriAM, LordRM, AllisonSJ, et al. Bis-Picolinamide ruthenium (III) dihalide complexes: dichloride to diiodide exchange generates single trans isomers with high potency and cancer cell selectivity. Chem - A Eur J. 2017;23(26):6341–6356. doi:10.1002/chem.201605960
   PubMed Web of Science ®Google Scholar
• MartínezÁM, RodríguezN, ArrayásRG, CarreteroJC. Copper-catalyzed ortho-C-H amination of protected anilines with secondary amines. Chem Commun. 2014;50(21):2801–2803. doi:10.1039/c3cc49633c
   PubMed Web of Science ®Google Scholar
• RastelliG, FerrariAM, CostantinoL, GamberiniMC. Discovery of new inhibitors of aldose reductase from molecular docking and database screening. Bioorg Med Chem. 2002;10(5):1437–1450. doi:10.1016/S0968-0896(01)00410-211886806
   PubMed Web of Science ®Google Scholar
• ZhuZW, ShiL, RuanXM, et al. Synthesis and antiproliferative activities against Hep-G2 of salicylanide derivatives: potent inhibitors of the epidermal growth factor receptor (EGFR) tyrosine kinase. J Enzyme Inhib Med Chem. 2011;26(1):37–45. doi:10.3109/1475636100367106020583855
   PubMed Web of Science ®Google Scholar
• GuoL, WangQL, JiangQQ, JiangQJ, JiangYB. Anion-triggered substituent-dependent conformational switching of salicylanilides. New hints for understanding the inhibitory mechanism of salicylanilides. J Org Chem. 2007;72(26):9947–9953. doi:10.1021/jo701823d18020364
   PubMed Web of Science ®Google Scholar
• HsiRSP, KalamazooM. Alkylcarbamates of cyanosalicyclanilides. United States Patent US 3317583. 1967.
   Google Scholar
• FengZ, ShenZ, YuanC, et al. p-Nitroaniline compound, preparation method thereof, pharmaceutical composition and application. Chinese Patent CN107434770. 2017.
   Google Scholar
• NairPM, AsasRS, VenkataramanK. Condensation of 2,4-Dinitrochlorobenzene with o-Hydroxyarylamides. Tetrahedron. 1969;11:140–147. doi:10.1016/0040-4020(60)80063-4
   Google Scholar
• BiagiG, GiorgiI, LiviO, et al. Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V. Eur J Med Chem. 2004;39(6):491–498. doi:10.1016/j.ejmech.2004.02.00615183907
   PubMed Web of Science ®Google Scholar
• WoodRD, WelshWJ, EkinsS, NiA. Glutamate Receptor Modulators and Therapeutic Agents. United States Patent US2009239919A1. 2009.
   Google Scholar
• ZhangJ, MaY, MaY. Synthesis of secondary amides through the Palladium(II)-Catalyzed aminocarbonylation of arylboronic acids with amines or hydrazines and carbon dioxide. Eur J Org Chem. 2018;2018(14):1720–1725. doi:10.1002/ejoc.201701802
   Web of Science ®Google Scholar
• DeviES, AlanthadkaA, TamilselviA, NagarajanS, SridharanV, MaheswariCU. Metal-free oxidative amidation of aldehydes with aminopyridines employing aqueous hydrogen peroxide. Org Biomol Chem. 2016;14:8228–8231. doi:10.1039/C6OB01454B27523309
   PubMed Web of Science ®Google Scholar
• RonsonTO, RendersE, Van SteijvoortBF, et al. Ruthenium-catalyzed reductive arylation of N-(2-Pyridinyl)amides with isopropanol and arylboronate esters. Angew Chemie - Int Ed. 2019;58(2):482–487. doi:10.1002/anie.v58.2
   PubMed Web of Science ®Google Scholar
• LoWS, HuWP, LoHP, et al. Synthesis of sulfur-sulfur bond formation from thioamides promoted by 2,3-dichloro-5,6-dicyanobenzoquinone. Org Lett. 2010;12(23):5570–5572. doi:10.1021/ol102455x21067153
   PubMed Web of Science ®Google Scholar
• ZuoM, ZhengYW, LuSM, LiY, ZhangSQ. Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC-EGFR dual inhibitors. Bioorg Med Chem. 2012;20(14):4405–4412. doi:10.1016/j.bmc.2012.05.03422698782
   PubMed Web of Science ®Google Scholar
• IslamAM, HannoutIB, HassanEA, IhsanAE. Synthesis of some substituted salicylanilides of expected biological activity. J Für Prakt Chemie. 1972;314:727–734. doi:10.1002/prac.19723140505
   Google Scholar
• LeeIY, GruberTD, SamuelsA, et al. Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling. Bioorg Med Chem. 2013;21(1):114–126. doi:10.1016/j.bmc.2012.10.05623211970
   PubMed Web of Science ®Google Scholar
• MutoS, ItaiA. PAI-1 production inhibitor. European Patent EP2201946A1. 2008.
   Google Scholar
• WaisserK, BurešO, HolýP, et al. Relationship between the structure and antimycobacterial activity of substituted salicylanilides. Arch Pharm Pharm Med Chem. 2003;336(1):53–71. doi:10.1002/ardp.200390004
   PubMed Web of Science ®Google Scholar
• KangS, MinHJ, KangMS, JungMG, KimS. Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors. Bioorg Med Chem Lett. 2013;23(6):1748–1751. doi:10.1016/j.bmcl.2013.01.05523414802
   PubMed Web of Science ®Google Scholar
• KozicJ, NovotnáE, VolkováM, StolaříkováJ, TrejtnarF, VinšováJ. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues. Eur J Med Chem. 2012;56:387–395. doi:10.1016/j.ejmech.2012.07.04422907036
   PubMed Web of Science ®Google Scholar
• ParaskevopoulosG, MonteiroS, VosátkaR, et al. Novel salicylanilides from 4,5-dihalogenated salicylic acids: synthesis, antimicrobial activity and cytotoxicity. Bioorg Med Chem. 2017;25(4):1524–1532. doi:10.1016/j.bmc.2017.01.01628126437
   PubMed Web of Science ®Google Scholar
• OzawaI, TakeuchiI, YamamotoK, et al. Synthesis and antimicrobial activity of salicylanilide derivatives. II. Chem Pharm Bull. 1984;32(1):305–312. doi:10.1248/cpb.32.3056722955
   PubMed Web of Science ®Google Scholar
• MutoS, ItaiA. NF-KB activation inhibitors. European Patent EP1535609A1. 2005.
   Google Scholar
• MookRA, ChenM, LuJ, BarakLS, LyerlyHK, ChenW. Small molecule modulators of Wnt/β-catenin signaling. Bioorg Med Chem Lett. 2013;23(7):2187–2191. doi:10.1016/j.bmcl.2013.01.10123453073
   PubMed Web of Science ®Google Scholar
• CalderoneV, CoiA, FiamingoFL, et al. Structural modifications of benzanilide derivatives, effective potassium channel openers. X. Eur J Med Chem. 2006;41(12):1421–1429. doi:10.1016/j.ejmech.2006.07.01617030483
   PubMed Web of Science ®Google Scholar
• DimitrovaN, ZamudioJR, JongRM, et al. Salicylanilide Inhibitors of Toxoplasma gondii. PLoS ONE. 2017;32(7):736–740.
   Google Scholar
• Ríos MartínezCH, Nué MartínezJJ, EbilomaGU, De KoningHP, AlkortaI, DardonvilleC. Lowering the pKa of a bisimidazoline lead with halogen atoms results in improved activity and selectivity against Trypanosoma brucei in vitro. Eur J Med Chem. 2015;101:806–817. doi:10.1016/j.ejmech.2015.07.01326231081
   PubMed Web of Science ®Google Scholar
• SaladiiohR, GentG, SummacV, NicoletticR, FochetdF, SpadaridS. Researches on antiviral agents. 41. studies on the chemistry of acyloxypyrimidine derivatives as new acylation reagents and inhibitors of Uracil DNA glycosylases. Tetrahedron. 1994;50(11):3603–3618. doi:10.1016/S0040-4020(01)87037-X
   Web of Science ®Google Scholar
• BottaM, De AngelisF, NicolettiR, PaniA, MarongiuME, La CollaP. 6-Alkyl-2-hethoxy-4-(3h)-pyrimidinones in the transformation of pyrimidines: regiospecific preparation, antitumor and antimicrobial activity of 4-O-acylated pyrimidine derivatives. New agents for selective acylation of amines. Tetrahedron Lett. 1988;29(22):2741–2744. doi:10.1016/0040-4039(88)85275-4
   Web of Science ®Google Scholar
• DubeySK, SinghAK, SinghH, et al. Synthesis of substituted l-Hydroxy-2-naphthanilides as potential cestodicidal agents. J Med Chem. 1978;21(11):1178–1181. doi:10.1021/jm00209a020722724
   PubMed Web of Science ®Google Scholar
• LiBX, YamanakaK, XiaoX. Structure – activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREB-mediated gene transcription. Bioorg Med Chem. 2012;20(23):6811–6820. doi:10.1016/j.bmc.2012.09.05623102993
   PubMed Web of Science ®Google Scholar
• SaikatsuH, FukudaT, OkamotoH, et al. Production method of asymmetrical polyazo dyes with good heat and light resistance for color filters and liquid crystal displays. International Patent WO 2011/078163 A1. 2011.
   Google Scholar
• HanSB, AchariR, KimMH, JongYS, KimPH. Novel compound or pharmaceutically acceptable salt thereof and pharmaceutical composition for prevention or treatment of disease caused by influenza virus infection containing the same as an active ingredient. Korean Patent KR2016/21163. 2016.
   Google Scholar